Journal profile · PHARMACOLOGY & PHARMACY
Pharmacy & Pharmacology-Farmatsiya i Farmakologiya
ISSN 2307-9266 · eISSN 2413-2241 · Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University · Russian Federation
Pharmacy & Pharmacology-Farmatsiya i Farmakologiya: CAS Zone 4 · Medicine (2025 upgraded edition); diamond open access (no APC); no APC; review about 8 weeks (community reports); 65 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Pharmacy & Pharmacology-Farmatsiya i Farmakologiya is published by Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacological Effects of Natural Compounds, Neurological Disorders and Treatments and Medicinal plant effects and applications, together about 23.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Цель журнала – обобщение научных и практических достижений в области фармации и фармакологии, повышение научной и практической квалификации работников фармацевтической сферы. Задачи: Освещать новые научные результаты в области фармации и фармакологии. Повышать открытость и доступность результатов научных работ научных и педагогических работников, аспирантов в различных областях фармации. Формировать стабильный интерес научной и научно-педагогической общественности, особенно у начинающих ученых и практических работников к современным вопросам и проблемам в фармации и фармакологии, освещаемым в журнале. Повышать профессиональный уровень фармацевтических, научных и педагогических работников, публикуя оригинальные статьи, результаты фундаментальных и прикладных исследований, направленных на разработку и изучение с целью оптимизации фармацевтического кластера, лекции и обзоры литературы по широкому спектру вопросов фармацевтических дисциплин, а также результаты доклинических и экспериментальных фармакологических исследований. Расширение аудитории авторов и читателей журнала за счёт привлечения как отечественных, так и зарубежных ученых и специалистов, работающих в области фармации, а также врачей-фармакологов.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Петров В.И.Publisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacological Effects of Natural CompoundsPharmacology, Toxicology and Pharmaceutics8.8%
- Neurological Disorders and TreatmentsNeuroscience7.6%
- Medicinal plant effects and applicationsMedicine7.6%
- Economic, Social, and Public Health Issues in Russia and GloballyDecision Sciences7.4%
- Phytochemical and Pharmacological StudiesMedicine7.4%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences5.6%
- Phytochemicals and Antioxidant ActivitiesMedicine5.1%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.1LetPub ·
- SJR 2026-06
- 0.15LetPub ·
- SNIP 2026-06
- 0.26LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 32OpenAlex ·
- 2-year mean citedness
- 0.98OpenAlex ·
- Self-citation rate
- 66.7%LetPub ·
- Share of gold OA articles
- 98.9%LetPub ·
Volume
- Articles per year
- 32LetPub ·
Articles by year OpenAlex count · 659 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 29 | 29 | 1 |
| 2025 | 65 | 65 | 60 |
| 2024 | 33 | 33 | 64 |
| 2023 | 29 | 29 | 85 |
| 2022 | 44 | 44 | 128 |
| 2021 | 73 | 73 | 254 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to first decision
- 28 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- 200–250 words
- Keywords
- 8–10
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
- Templates
- Word
- Cover letter
- Required
Article types accepted13
- информационные технологии в фармацииИНФОРМАЦИОННЫЕ ТЕХНОЛОГИИ В ФАРМАЦИИLength not stated
- некрологНЕКРОЛОГLength not stated
- обзоры, лекцииОБЗОРЫ, ЛЕКЦИИLength not stated
- организация и экономика фармацевтического делаОРГАНИЗАЦИЯ И ЭКОНОМИКА ФАРМАЦЕВТИЧЕСКОГО ДЕЛАLength not stated
- оригинальная статьяОРИГИНАЛЬНАЯ СТАТЬЯLength not stated
- оригинальные статьи. обзоры, лекцииОРИГИНАЛЬНЫЕ СТАТЬИ. ОБЗОРЫ, ЛЕКЦИИLength not stated
- фармакология и клиническая фармакологияФАРМАКОЛОГИЯ И КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯLength not stated
- фармакология, клиническая фармакологияФАРМАКОЛОГИЯ, КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯLength not stated
- фармацевтическая и токсикологическая химияФАРМАЦЕВТИЧЕСКАЯ И ТОКСИКОЛОГИЧЕСКАЯ ХИМИЯLength not stated
- фармацевтическая технология и биотехнологияФАРМАЦЕВТИЧЕСКАЯ ТЕХНОЛОГИЯ И БИОТЕХНОЛОГИЯLength not stated
- фармацевтическое образованиеФАРМАЦЕВТИЧЕСКОЕ ОБРАЗОВАНИЕLength not stated
- экономика и менеджмент медициныЭКОНОМИКА И МЕНЕДЖМЕНТ МЕДИЦИНЫLength not stated
- юбилеиЮБИЛЕИLength not stated
Policy excerpts from the journal's websiteLicense & copyright, Peer review
- License & copyright
Creative Commons Attribution 4.0 License Model summary
Контент доступен под лицензией Creative Commons Attribution 4.0 License.
Source ↗Publisher website ·- Peer review
Двойное слепое рецензирование Model summary
Все рукописи, поступившие в редакцию журнала «Фармация и фармакология», проходят обязательное двойное слепое рецензирование (рецензент не знает авторов рукописи, авторы рукописи не знаю рецензентов).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
- Country or region
- Russian Federation
- Language
- Russian
- ISSN
- 2307-9266
- Electronic ISSN
- 2413-2241
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Pharmacy & Pharmacology-Farmatsiya i Farmakologiya
What CAS zone is Pharmacy & Pharmacology-Farmatsiya i Farmakologiya in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pharmacy & Pharmacology-Farmatsiya i Farmakologiya is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Pharmacy & Pharmacology-Farmatsiya i Farmakologiya?
Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pharmacy & Pharmacology-Farmatsiya i Farmakologiya?
According to the journal's author guidelines: Abstract: 200–250 words; Keywords: 8–10; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation; Templates: Word; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Pharmacy & Pharmacology-Farmatsiya i Farmakologiya?
According to LetPub and DOAJ records, Pharmacy & Pharmacology-Farmatsiya i Farmakologiya is indexed in ESCI, Scopus and DOAJ.
Is Pharmacy & Pharmacology-Farmatsiya i Farmakologiya open access, and what is the APC?
Pharmacy & Pharmacology-Farmatsiya i Farmakologiya is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .